News

The company plans to file a new drug application with the FDA within the next few months for its lead product candidate, bucindolol, for the treatment of chronic

The one-year pooled Arrive data confirmed the known higher mortality rate for diabetics versus non-diabetics with cardiovascular disease, but showed that the Taxus Stent had similarly low rates

In this trial, Prasugrel has reduced the relative risk of coronary stent thrombosis (a new clot at the implanted stent site) over clopidogrel by 52% (1.13% versus 2.35%,

Under the terms of the agreement, Artech placed an initial stocking order for E90,000 (approximately $144,000) for RenalGuard Consoles and single use sets to support the initial sales

Under an international innovation subsidy granted by SenterNovem, an agency of the Dutch Ministry of Economic Affairs, DNage has initiated a project with the Eberhard Karls University in

The Tantalus System is designed to sense naturally occurring electrical activity of the stomach in real time and automatically apply electrical stimulation when a person eats. To be

In addition, 30% of the patients treated using the combination therapy required only a single combination treatment compared to Avastin monotherapy, with which all patients required additional treatments.

This payment is a result of the submission of an investigational new drug application by Novo Nordisk for the clinical development of an antibody generated by Medarex’s UltiMAb

The promising data from the study, which was initiated by NeoVista to test the efficacy and safety of their novel therapy when used in conjunction with Avastin (bevacizumab),